{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T23:16:11Z","timestamp":1773098171425,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.jinf.2018.01.003","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T07:43:41Z","timestamp":1517384621000},"page":"342-347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Effectiveness of combination therapy versus monotherapy with a third-generation cephalosporin in bacteraemic pneumococcal pneumonia: A propensity score analysis"],"prefix":"10.1016","volume":"76","author":[{"given":"C.","family":"De la Calle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.G.","family":"Ternavasio-de la Vega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Morata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Marco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Cardozo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Garc\u00eda-Vidal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Del Rio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Cilloniz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Mensa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jinf.2018.01.003_bib0010","first-page":"494","article-title":"The incidence rate and economic burden of community-acquired pneumonia in a working-age population","volume":"6","author":"Broulette","year":"2013","journal-title":"Am Health Drug Benefits"},{"issue":"Suppl 3","key":"10.1016\/j.jinf.2018.01.003_bib0015","doi-asserted-by":"crossref","first-page":"iii1","DOI":"10.1136\/thx.2009.121434","article-title":"BTS guidelines for the management of community acquired pneumonia in adults: update 2009","volume":"64","author":"Lim","year":"2009","journal-title":"Thorax"},{"issue":"Suppl 6","key":"10.1016\/j.jinf.2018.01.003_bib0020","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1469-0691.2011.03672.x","article-title":"Guidelines for the management of adult lower respiratory tract infections\u2013full version","volume":"17","author":"Woodhead","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"10.1016\/j.jinf.2018.01.003_bib0025","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/jac\/dku033","article-title":"\u03b2-Lactam\/macrolide dual therapy versus \u03b2-lactam monotherapy for the treatment of community-acquired pneumonia in adults: a systematic review and meta-analysis","volume":"69","author":"Nie","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"14","key":"10.1016\/j.jinf.2018.01.003_bib0030","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1056\/NEJMoa1406330","article-title":"Antibiotic treatment strategies for community-acquired pneumonia in adults","volume":"372","author":"Postma","year":"2015","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jinf.2018.01.003_bib0035","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s15010-015-0837-z","article-title":"Bacteremic pneumococcal pneumonia: clinical outcomes and preliminary results of inflammatory response","volume":"43","author":"Bordon","year":"2015","journal-title":"Infection"},{"key":"10.1016\/j.jinf.2018.01.003_bib0040","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1183\/09031936.00128107","article-title":"Early mortality in patients with community-acquired pneumonia: causes and risk factors","volume":"32","author":"Garcia-Vidal","year":"2008","journal-title":"Eur Respir J"},{"issue":"15","key":"10.1016\/j.jinf.2018.01.003_bib0045","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1001\/archinte.161.15.1837","article-title":"Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia","volume":"161","author":"Waterer","year":"2001","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.1016\/j.jinf.2018.01.003_bib0050","first-page":"589","article-title":"Clinical characteristics at initial presentation and impact of dual therapy on the outcome of bacteremic Streptococcus pneumoniae pneumonia in adults","volume":"11","author":"Weiss","year":"2004","journal-title":"Can Respir J"},{"issue":"8","key":"10.1016\/j.jinf.2018.01.003_bib0055","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s10096-006-0183-2","article-title":"Addition of a macrolide to a ss-lactam in bacteremic pneumococcal pneumonia","volume":"25","author":"Dwyer","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"10.1016\/j.jinf.2018.01.003_bib0060","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/thoraxjnl-2012-203106","article-title":"Contribution of host, bacterial factors and antibiotic treatment to mortality in adult patients with bacteraemic pneumococcal pneumonia","volume":"68","author":"Naucler","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.jinf.2018.01.003_bib0065","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archinte.1962.03620240038007","article-title":"Gram-negative bacteremia: II. clinical, laboratory, and therapeutic observations","volume":"110","author":"McCabe","year":"1962","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jinf.2018.01.003_bib0070","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1080\/01621459.1984.10478078","article-title":"Reducing bias in observational studies using subclassification on the propensity score","volume":"79","author":"Rosenbaum","year":"1984","journal-title":"J Am Stat Assoc"},{"issue":"12","key":"10.1016\/j.jinf.2018.01.003_bib0075","doi-asserted-by":"crossref","first-page":"7025","DOI":"10.1128\/AAC.03796-14","article-title":"A propensity score analysis shows that empirical treatment with linezolid does not increase the thirty-day mortality rate in patients with gram-negative bacteremia","volume":"58","author":"Ternavasio-de la Vega","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.jinf.2018.01.003_bib0080","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/pst.433","article-title":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies","volume":"10","author":"Austin","year":"2011","journal-title":"Pharm Stat"},{"issue":"5","key":"10.1016\/j.jinf.2018.01.003_bib0085","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.jtcvs.2007.07.021","article-title":"Propensity-score matching in the cardiovascular surgery literature from 2004 to 2006: a systematic review and suggestions for improvement","volume":"134","author":"Austin","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"20","key":"10.1016\/j.jinf.2018.01.003_bib0090","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1002\/sim.3854","article-title":"The performance of different propensity-score methods for estimating differences in proportions (risk differences or absolute risk reductions) in observational studies","volume":"29","author":"Austin","year":"2010","journal-title":"Stat Med"},{"issue":"10","key":"10.1016\/j.jinf.2018.01.003_bib0095","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/cid\/ciu158","article-title":"Initial use of echinocandins does not negatively influence outcome in Candida parapsilosis bloodstream infection: a propensity score analysis","volume":"58","author":"Fern\u00e1ndez-Ruiz","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2018.01.003_bib0100","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1080\/00273171.2011.540475","article-title":"A systematic review of propensity score methods in the social sciences","volume":"46","author":"Thoemmes","year":"2011","journal-title":"Multivariate Behav Res"},{"issue":"1A","key":"10.1016\/j.jinf.2018.01.003_bib0105","doi-asserted-by":"crossref","first-page":"34S","DOI":"10.1016\/S0002-9343(99)00098-4","article-title":"Bacteremic pneumococcal pneumonia in one American City: a 20-year longitudinal study, 1978\u20131997","volume":"107","author":"Mufson","year":"1999","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.jinf.2018.01.003_bib0110","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1086\/367541","article-title":"Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia","volume":"36","author":"Mart\u00ednez","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.jinf.2018.01.003_bib0115","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1001\/jamainternmed.2014.4887","article-title":"\u03b2-Lactam monotherapy vs \u03b2-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial","volume":"174","author":"Garin","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"5","key":"10.1016\/j.jinf.2018.01.003_bib0120","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1136\/thoraxjnl-2012-202296","article-title":"Single versus combination antibiotic therapy in adults hospitalised with community acquired pneumonia","volume":"68","author":"Rodrigo","year":"2013","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.jinf.2018.01.003_bib0125","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1177\/039463201002300318","article-title":"In vitro activity of cefditoren versus other antibiotics against S. pneumoniae clinical strains isolated in Italy","volume":"23","author":"Tempera","year":"2010","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"6","key":"10.1016\/j.jinf.2018.01.003_bib0130","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1097\/01.CCM.0000266755.75844.05","article-title":"Combination antibiotic therapy improves survival in patients with community-acquired pneumonia and shock","volume":"35","author":"Rodr\u00edguez","year":"2007","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.jinf.2018.01.003_bib0135","doi-asserted-by":"crossref","first-page":"R8","DOI":"10.1186\/cc3934","article-title":"The impact of empiric antimicrobial therapy with a \u03b2-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia","volume":"10","author":"Mortensen","year":"2005","journal-title":"Crit Care"},{"issue":"4","key":"10.1016\/j.jinf.2018.01.003_bib0140","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cmi.2016.12.002","article-title":"Fluoroquinolones or macrolides in combination with \u03b2-lactams in adult patients hospitalized with community acquired pneumonia: a systematic review and meta-analysis","volume":"23","author":"Vardakas","year":"2017","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.jinf.2018.01.003_bib0145","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/jac\/dkr016","article-title":"Comparative evaluation of synergy of combinations of beta-lactams with fluoroquinolones or a macrolide in Streptococcus pneumoniae","volume":"66","author":"Drago","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.jinf.2018.01.003_bib0150","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/jac\/46.6.973","article-title":"Antagonism between penicillin and erythromycin against Streptococcus pneumoniae in vitro and in vivo","volume":"46","author":"Johansen","year":"2000","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.jinf.2018.01.003_bib0155","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ijantimicag.2004.02.030","article-title":"In vitro antagonism between beta-lactam and macrolide in Streptococcus pneumoniae: how important is the antibiotic order?","volume":"24","author":"Ortega","year":"2004","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.jinf.2018.01.003_bib0160","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1128\/AAC.45.1.44-47.2001","article-title":"Clarithromycin inhibits NF-kappaB activation in human peripheral blood mononuclear cells and pulmonary epithelial cells","volume":"45","author":"Ichiyama","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1016\/j.jinf.2018.01.003_bib0165","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1128\/AAC.47.12.3704-3707.2003","article-title":"Effect of moxifloxacin on production of proinflammatory cytokines from human peripheral blood mononuclear cells","volume":"47","author":"Choi","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.jinf.2018.01.003_bib0170","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1128\/AAC.00658-07","article-title":"Systemic expression of cytokine production in patients with severe pneumococcal pneumonia: effects of treatment with a beta-lactam versus a fluoroquinolone","volume":"52","author":"Calbo","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.jinf.2018.01.003_bib0175","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.pharmthera.2007.11.001","article-title":"Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action","volume":"117","author":"Shinkai","year":"2008","journal-title":"Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.jinf.2018.01.003_bib0180","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/jac\/dkr520","article-title":"Immunomodulatory effects of macrolides during community-acquired pneumonia: a literature review","volume":"67","author":"Kovaleva","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.jinf.2018.01.003_bib0185","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/jac\/dkl479","article-title":"Clarithromycin alone and in combination with ceftriaxone inhibits the production of pneumolysin by both macrolide-susceptible and macrolide-resistant strains of Streptococcus pneumoniae","volume":"59","author":"Anderson","year":"2007","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.jinf.2018.01.003_bib0190","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1183\/09031936.06.00116805","article-title":"Effects of macrolides on pneumolysin of macrolide-resistant Streptococcus pneumoniae","volume":"27","author":"Fukuda","year":"2006","journal-title":"Eur Respir J"},{"issue":"9","key":"10.1016\/j.jinf.2018.01.003_bib0195","doi-asserted-by":"crossref","first-page":"5164","DOI":"10.1128\/AAC.03245-14","article-title":"Levofloxacin-ceftriaxone combination attenuates lung inflammation in a mouse model of bacteremic pneumonia caused by multidrug-resistant Streptococcus pneumoniae via inhibition of cytolytic activities of pneumolysin and autolysin","volume":"58","author":"Majhi","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.jinf.2018.01.003_bib0200","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1172\/JCI117631","article-title":"Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia","volume":"95","author":"Rubins","year":"1995","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.jinf.2018.01.003_bib0205","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/cid\/ciu304","article-title":"Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections","volume":"59","author":"Carapetis","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.jinf.2018.01.003_bib0210","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10096-005-1346-2","article-title":"Community-acquired pneumonia of mixed etiology: prevalence, clinical characteristics, and outcome","volume":"24","author":"Guti\u00e9rrez","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445318300203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445318300203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:25:42Z","timestamp":1759008342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445318300203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0163445318300203"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2018.01.003","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732543267.793548194","asserted-by":"object"}]},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of combination therapy versus monotherapy with a third-generation cephalosporin in bacteraemic pneumococcal pneumonia: A propensity score analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2018.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}